The digital content on TLO has been updated to align with the accessibility standards required by WCAG 2.1.

Skip to main content
Texas Capitol
89th Legislature Second Called Session
Texas Legislature Online


History for 88(R) SB 426 by Paxton

Last Action:
04/17/2023 H Referred to Public Health: Apr 17 2023 1:42PM
Council Document:
88R 1010 KKR-F
Caption Version:
Engrossed
Caption Text:
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Author:
Paxton
Coauthor:
Hall
Subjects:
Health Care Providers (I0387)
Health--General (I0385)
Health--Other Diseases & Medical Conditions (I0383)
RIGHT TO TREAT ACT (P17XY)
COVID-19 (SB9YM)
MEDICINE & PRESCRIPTION DRUGS (S7338)
MEDICAL BOARD, TEXAS (V0644)
Senate Committee:
Health & Human Services
Senate Committee Status:
Out of committee
Senate Committee Vote:
Ayes=9   Nays=0   Present Not Voting=0   Absent=0
House Committee:
Public Health
House Committee Status:
In committee
Actions are in descending date order.
Viewing Votes: Most Recent Senate Vote
Description Comment DateSort descending       Time       Journal Page
H   Referred to Public Health      04/17/2023   01:42 PM  1528
H   Read first time      04/17/2023     1528
H   Received from the Senate      04/06/2023     1282
S   Reported engrossed      04/05/2023     806
S   Record vote      04/05/2023     791
S   Passed      04/05/2023     791
S   Read 3rd time      04/05/2023     791
S   Record vote      04/05/2023     791
S   Three day rule suspended      04/05/2023     790
S   Vote recorded in Journal      04/05/2023     790
S   Passed to engrossment as amended      04/05/2023     790
S   Vote recorded in Journal      04/05/2023     790
S   Amended      04/05/2023     790
S   Amendment(s) offered   FA1 Paxton   04/05/2023     790
S   Read 2nd time      04/05/2023     790
S   Vote recorded in Journal      04/05/2023     790
S   Rules suspended-Regular order of business      04/05/2023     790
S   Placed on intent calendar      04/04/2023    
S   Committee report printed and distributed      03/31/2023   06:19 PM 
S   Reported favorably w/o amendments      03/31/2023     706
S   Vote taken in committee      03/29/2023    
S   Considered in public hearing      03/29/2023    
S   Co-author authorized      03/27/2023     636
S   Left pending in committee      03/22/2023    
S   Testimony taken in committee      03/22/2023    
S   Considered in public hearing      03/22/2023    
S   Scheduled for public hearing on . . .      03/22/2023    
S   Referred to Health & Human Services      02/15/2023     184
S   Read first time      02/15/2023     184
S   Filed      01/12/2023    
S   Received by the Secretary of the Senate      01/12/2023